- Home
- HKIT vs IPSC Comparison
HKIT vs IPSC Comparison
Compare HKIT & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- IPSC
- Stock Information
- Founded
- HKIT 1996
- IPSC 2019
- Country
- HKIT China
- IPSC United States
- Employees
- HKIT N/A
- IPSC N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- HKIT Technology
- IPSC Health Care
- Exchange
- HKIT Nasdaq
- IPSC Nasdaq
- Market Cap
- HKIT 39.8M
- IPSC 47.4M
- IPO Year
- HKIT 2023
- IPSC 2021
- Fundamental
- Price
- HKIT $1.40
- IPSC $0.58
- Analyst Decision
- HKIT
- IPSC Strong Buy
- Analyst Count
- HKIT 0
- IPSC 5
- Target Price
- HKIT N/A
- IPSC $3.33
- AVG Volume (30 Days)
- HKIT 7.7K
- IPSC 1.0M
- Earning Date
- HKIT 04-29-2025
- IPSC 08-07-2025
- Dividend Yield
- HKIT N/A
- IPSC N/A
- EPS Growth
- HKIT N/A
- IPSC N/A
- EPS
- HKIT N/A
- IPSC N/A
- Revenue
- HKIT $2,904,950.00
- IPSC $114,898,000.00
- Revenue This Year
- HKIT N/A
- IPSC $1,590.09
- Revenue Next Year
- HKIT N/A
- IPSC N/A
- P/E Ratio
- HKIT N/A
- IPSC N/A
- Revenue Growth
- HKIT N/A
- IPSC 8286.72
- 52 Week Low
- HKIT $1.15
- IPSC $0.34
- 52 Week High
- HKIT $1.86
- IPSC $3.00
- Technical
- Relative Strength Index (RSI)
- HKIT 50.59
- IPSC 52.96
- Support Level
- HKIT $1.33
- IPSC $0.56
- Resistance Level
- HKIT $1.45
- IPSC $0.61
- Average True Range (ATR)
- HKIT 0.05
- IPSC 0.03
- MACD
- HKIT -0.00
- IPSC 0.00
- Stochastic Oscillator
- HKIT 46.31
- IPSC 55.23
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.